Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 18.3% in the morning session after the company announced positive top-line results from its Phase 3 HERIZON-GEA-01 trial for its ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

The FMI report, “Mercaptopropionic Acid Market Size, Share, and Forecast 2025–2035,” highlights that global revenues will ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...

President Donald Trump is set to fete Crown Prince Mohammed bin Salman on Tuesday when the de facto leader of Saudi Arabia ...

The Memphis Tigers will have their work cut out for them this week in a competitive four-team field in the 2025 Baha Mar ...

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based ...

Geographic diversification, US tech, AI, energy, commodities and local value plays in equities — that’s the guidance that ...

Can UK science really spawn a $1-trillion company? That’s not to downplay the successes. The United Kingdom is ranked fourth ...

AI bubble talk continues to fizz, but Amazon founder Jeff Bezos—one of the world’s richest people—doesn’t seem bothered by ...

Discovery in U.S. litigation, especially document review, can often be a lengthy and expensive process. This naturally raises ...

From securing an additional 15% investment for R&D, to depositing ROI gains into a “cash bucket” for future projects, ...